810130C

16:0-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810130C

• Synonym(s): 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• Empirical Formula (Hill Notation): C₃₆H₆₂N₅O₁₁P
• CAS Number: 91992-01-7
• Molecular Weight: 771.88
• UNSPSC Code: 12352211
• NACRES: NA.25

Properties

• Assay: >99% (TLC)
• form: liquid
• packaging: pkg of 1 × 1 mL (810130C-1mg); pkg of 5 × 1 mL (810130C-5mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 810130C
• concentration: 1 mg/mL (810130C-1mg); 1 mg/mL (810130C-5mg)
• shipped in: dry ice
• storage temp.: −20°C

Description

General description

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 16:0-06:0 NBD PC is a fluorescent lipid.

Application

16:0-06:0 NBD PC I suitable for use:

• in the preparation of fluid phase fluorescent bilayers
• to prepare liposomes/small unilamellar vesicles (SUVs)
• as substrate in in vitro enzyme assay of lipoteichoic acid (LTA) synthase enzyme (LtaS) to determine the enzyme specificity

Packaging

5 mL Amber Glass Screw Cap Vial (810130C-1mg)

5 mL Amber Glass Screw Cap Vial (810130C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Safety Information

• Pictograms: GHS06,GHS08
• Signal Word: Danger
• Hazard Statements: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• Precautionary Statements: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Target Organs: Central nervous system, Liver,Kidney
• WGK: WGK 3